MEDX holdings
Horizon Kinetics Medical ETF
Positions
33 stored of 33 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | US5324571083 | 532457108 | 18.460% | $3.5M | Equity (common) | Corporate | United States | USD |
| 2 | US BANK MMDA - USBGFS 7 | Not reported | Not reported | 9.187% | $1.8M | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |
| 3 | AbbVie Inc | US00287Y1091 | 00287Y109 | 8.854% | $1.7M | Equity (common) | Corporate | United States | USD |
| 4 | Novartis AG | US66987V1098 | 66987V109 | 6.891% | $1.3M | Equity (common) | Corporate | Switzerland | USD |
| 5 | Johnson & Johnson | US4781601046 | 478160104 | 5.591% | $1.1M | Equity (common) | Corporate | United States | USD |
| 6 | Alkermes PLC | IE00B56GVS15 | Not reported | 5.529% | $1.1M | Equity (common) | Corporate | Ireland | USD |
| 7 | AstraZeneca PLC | GB0009895292 | Not reported | 4.985% | $951K | Equity (common) | Corporate | United Kingdom | USD |
| 8 | Ionis Pharmaceuticals Inc | US4622221004 | 462222100 | 4.532% | $865K | Equity (common) | Corporate | United States | USD |
| 9 | Bristol-Myers Squibb Co | US1101221083 | 110122108 | 4.423% | $844K | Equity (common) | Corporate | United States | USD |
| 10 | Merck & Co Inc | US58933Y1055 | 58933Y105 | 3.955% | $755K | Equity (common) | Corporate | United States | USD |
| 11 | Amgen Inc | US0311621009 | 031162100 | 3.914% | $747K | Equity (common) | Corporate | United States | USD |
| 12 | Alnylam Pharmaceuticals Inc | US02043Q1076 | 02043Q107 | 3.421% | $653K | Equity (common) | Corporate | United States | USD |
| 13 | Biogen Inc | US09062X1037 | 09062X103 | 3.087% | $589K | Equity (common) | Corporate | United States | USD |
| 14 | Pfizer Inc | US7170811035 | 717081103 | 2.859% | $545K | Equity (common) | Corporate | United States | USD |
| 15 | GSK PLC | US37733W2044 | 37733W204 | 2.706% | $516K | Equity (common) | Corporate | United Kingdom | USD |
| 16 | CRISPR Therapeutics AG | CH0334081137 | Not reported | 2.638% | $503K | Equity (common) | Corporate | Switzerland | USD |
| 17 | Regeneron Pharmaceuticals Inc | US75886F1075 | 75886F107 | 2.059% | $393K | Equity (common) | Corporate | United States | USD |
| 18 | Beam Therapeutics Inc | US07373V1052 | 07373V105 | 1.509% | $288K | Equity (common) | Corporate | United States | USD |
| 19 | Galectin Therapeutics Inc | US3632252025 | 363225202 | 1.142% | $218K | Equity (common) | Corporate | United States | USD |
| 20 | Intellia Therapeutics Inc | US45826J1051 | 45826J105 | 1.116% | $213K | Equity (common) | Corporate | United States | USD |
| 21 | Sandoz Group AG | US7999261008 | 799926100 | 0.797% | $152K | Equity (common) | Corporate | Switzerland | USD |
| 22 | Replimune Group Inc | US76029N1063 | 76029N106 | 0.730% | $139K | Equity (common) | Corporate | United States | USD |
| 23 | Vanda Pharmaceuticals Inc | US9216591084 | 921659108 | 0.727% | $139K | Equity (common) | Corporate | United States | USD |
| 24 | Haleon PLC | US4055521003 | 405552100 | 0.602% | $115K | Equity (common) | Corporate | United Kingdom | USD |
| 25 | Lantern Pharma Inc | US51654W1018 | 51654W101 | 0.550% | $105K | Equity (common) | Corporate | United States | USD |
| 26 | Editas Medicine Inc | US28106W1036 | 28106W103 | 0.470% | $90K | Equity (common) | Corporate | United States | USD |
| 27 | GE HealthCare Technologies Inc | US36266G1076 | 36266G107 | 0.282% | $54K | Equity (common) | Corporate | United States | USD |
| 28 | Bicycle Therapeutics PLC | US0887861088 | 088786108 | 0.280% | $53K | Equity (common) | Corporate | United Kingdom | USD |
| 29 | Viatris Inc | US92556V1061 | 92556V106 | 0.260% | $50K | Equity (common) | Corporate | United States | USD |
| 30 | Allogene Therapeutics Inc | US0197701065 | 019770106 | 0.183% | $35K | Equity (common) | Corporate | United States | USD |
| 31 | Pacific Biosciences of Califor Pacific Biosciences of California Inc | US69404D1081 | 69404D108 | 0.089% | $17K | Equity (common) | Corporate | United States | USD |
| 32 | Decoy Therapeutics Inc | US79400X6022 | 79400X602 | <0.001% | $149 | Equity (common) | Corporate | United States | USD |
| 33 | Pathos AI Inc | Not reported | Not reported | 0.000% | $0 | Equity (common) | Corporate | United States | USD |